Liposomal formulations of anticancer copper(ii) thiosemicarbazone complexes

por Mathuber, Marlene, Hager, Sonja, Keppler, Bernhard K., Heffeter, Petra, Kowol, Christian R.
Publicado 2021

Synthesis, Characterization and in vitro Studies of a Cathepsin B‐Cleavable Prodrug of the VEGFR Inhibitor Sunitinib

por Karnthaler‐Benbakka, Claudia, Koblmüller, Bettina, Mathuber, Marlene, Holste, Katharina, Berger, Walter, Heffeter, Petra, Kowol, Christian R., Keppler, Bernhard K.
Publicado 2018

Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs

por Mathuber, Marlene, Schueffl, Hemma, Dömötör, Orsolya, Karnthaler, Claudia, Enyedy, Éva A., Heffeter, Petra, Keppler, Bernhard K., Kowol, Christian R.
Publicado 2020

Development of a cobalt(iii)-based ponatinib prodrug system

por Mathuber, Marlene, Gutmann, Michael, La Franca, Mery, Vician, Petra, Laemmerer, Anna, Moser, Patrick, Keppler, Bernhard K., Berger, Walter, Kowol, Christian R.
Publicado 2021

Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Eff...

por Bormio Nunes, Julia H., Hager, Sonja, Mathuber, Marlene, Pósa, Vivien, Roller, Alexander, Enyedy, Éva A., Stefanelli, Alessia, Berger, Walter, Keppler, Bernhard K., Heffeter, Petra, Kowol, Christian R.
Publicado 2020

Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance

por Pósa, Vivien, Stefanelli, Alessia, Nunes, Julia H. Bormio, Hager, Sonja, Mathuber, Marlene, May, Nóra V., Berger, Walter, Keppler, Bernhard K., Kowol, Christian R., Enyedy, Éva A., Heffeter, Petra
Publicado 2022